CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
Hematologic Oncology Update
00:00
Recognizing and managing CRS and ICANS
Patients describe symptoms; experts review fever, neurotoxicity, tocilizumab and steroid management.
Play episode from 28:13
Transcript
